Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic assist devices.

A A Demetriou1

  • 1Department of Surgery, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA. Achilles.Demetriou@cshs.org

Panminerva Medica
|June 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and testing of a bioartificial liver.

Surgical technology international·2015
Same author

Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat.

Gut·2007
Same author

Serum bile acids in patients with liver failure supported with a bioartificial liver.

Alimentary pharmacology & therapeutics·2002
Same author

Activation of hepatic stellate cells in liver tissue of patients with fulminant liver failure after treatment with bioartificial liver.

Human pathology·2002
Same author

Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells.

Biochemical and biophysical research communications·2001
Same author

Enhanced proliferation and differentiation of rat hepatocytes cultured with bone marrow stromal cells.

Journal of cellular physiology·2001
Same journal

Circulating osteopontin and body composition in systemic lupus erythematosus: a cross-sectional study.

Panminerva medica·2026
Same journal

Fluid de-resuscitation in critical illness: are we measuring the right endpoint?

Panminerva medica·2026
Same journal

A standardized Ferula supplement (Menotrack) to prevent symptoms in post-menopause: a 3-month supplement registry.

Panminerva medica·2026
Same journal

Impact of cardiogenic shock on outcomes in patients with spontaneous coronary artery dissection: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Characteristics and outcomes of spontaneous coronary artery dissection versus Takotsubo Syndrome: a systematic review and meta-analysis.

Panminerva medica·2026
Same journal

Medical decluttering: what it is and why it is important.

Panminerva medica·2026
See all related articles

Acute liver failure (ALF) survival is improving, but liver transplantation is limited by donor shortage. Liver support systems, both biological and non-biological, offer temporary aid for ALF patients awaiting recovery or transplant.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Critical Care Medicine

Background:

  • Acute liver failure (ALF) presents significant morbidity and mortality challenges.
  • Improved understanding of ALF pathophysiology and patient management have increased survival rates.
  • Liver transplantation is the definitive treatment but is constrained by organ donor scarcity.

Purpose of the Study:

  • To review current liver support strategies for patients with severe ALF.
  • To evaluate the capabilities and limitations of non-biological and biological liver support systems.
  • To discuss the future role of these systems in managing liver failure.

Main Methods:

  • Review of non-biological liver support systems (plasma exchange, hemodialysis, hemofiltration, hemoperfusion).

Related Experiment Videos

  • Review of biological liver support systems (ex vivo perfusion, hepatocyte-based devices).
  • Discussion of limitations, particularly the need for effective human hepatocyte cell lines.

    • Main Results:

    • Non-biological systems excel at toxin removal but lack synthetic function.
    • Biological systems offer detoxification, biotransformation, and biosynthetic functions.
    • Current biological systems utilize porcine hepatocytes or hepatoma cell lines due to a lack of suitable human cell lines.

    Conclusions:

    • Liver support strategies are crucial for managing ALF patients awaiting transplantation or recovery.
    • Both biological and non-biological systems have roles in treating specific forms of liver failure.
    • Advancements in cell therapy are needed to optimize biological liver support systems.